Epcoritamab,rituximab,cyclophosphamide,doxorubicin,vincristine,prednisone,lenalidomide,bendamustine,cytarabine,dexamethasone,oxaliplatin,carboplatin,gemcitabine,ifosfamide
Genmab,Abbvie
['nhl', 'lymsm']
epocr-nhl-2 trial using epco-r2 in rr fl showing orr 97% and cmr 86%. second line fl getting crowded #asco23 #lymsm
An associate member @MoffittNews with interest in #lymsm. Tweets are not endorsements, and not medical advice.